SU056 - ≥98% , CAS No.2376580-08-2

CAS: 2376580-08-2 Cat. No.: S651844 Peso molecular: 369.34

GRADE & PURITY ≥98%

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Descripción general

SU056 is a YB-1 inhibitor. SU056 induces cell-cycle arrest, apoptosis , and inhibits cell migration in ovarian cancer cells. SU056 interacts with YB-1 and inhibits and its associated downstream proteins and pathways. SU056 can enhance the cytotoxic effects of Paclitaxel

In Vitro

SU056 (0-10 μM approximately, 48 h) inhibits cell growth in OVCAR3/4/5/8, SKOV3 and ID8 cells。 SU056 (1 μM, 5-8 days) inhibits colony formation in a dose-dependent manner in OVCAR-8 and ID8 cells。 SU056 (1-5 μM, 6 h) arrests OVCAR8, SKOV3, and ID8 cells in the sub-G1 and G1 phases. SU056 (0-1 μM, 12 h) inhibits cell migration in OVCAR8, SKOV3, and ID8 cells. SU056 (0-5 μM, 24 h) induces apoptotic cell death in OVCAR8, SKOV3, and ID8 cells. SU056 (1-5 μM, 12 h) inhibited the expression of YB-1, TMSB10, SUMO2, and PMSB2 proteins in OVCAR8 cells. SU056 (0.1, 0.5, and 1 μM, 48 h) enhances the cytotoxic effects of Paclitaxel (0.1, 0.5, and 1 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: OVCAR3/4/5/8, SKOV3 and ID8 cells Concentration: 0-10 μM approximately Incubation Time: 48 h Result: Inhibited cell growth with IC 50 values of 1.27, 6.8, 4.33, 3.18, 1.73, 3.75 μM. Cell Migration AssayCell Line: OVCAR8, SKOV3, and ID8 cells Concentration: 0, 0.5, 1 μM Incubation Time: 12 h Result: Dose-dependently inhibited cell migration. Western Blot AnalysisCell Line: OVCAR8 cell Concentration: 1-5 μM Incubation Time: 12 h Result: Dose-dependently inhibited the YB-1, TMSB10, SUMO2, and PMSB2 proteins.

In Vivo

SU056 (20 mg/kg, i.p.) inhibits tumor growth in mice implanted with ID8 cells . SU056 (10 mg/kg, i.p., daily) combined with Paclitaxel (5 mg/kg, weekly, i.p.) shows a much greater reduction in OC tumor growth in immunodeficiency mice implanted with OVCAR8 OC tumors . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: C57BL/6 mice implanted (s.c.) with luciferase-expressing ID8 cells Dosage: 20 mg/kg Administration: Intraperitoneal injection (i.p.) Result: Reduced the tumor weight by 2-fold, and is well-tolerated. Reduced the lung metastases. Inhibited YB-1 expression and downstream MDR1 (IHC assay of tumor sample).

Form:Solid

IC50& Target:YB-1

Specifications

Especificaciones y pureza

≥98%

Mecanismos bioquímicos y fisiológicos

SU056 is a YB-1 inhibitor. SU056 induces cell-cycle arrest, apoptosis , and inhibits cell migration in ovarian cancer cells. SU056 interacts with YB-1 and inhibits and its associated downstream proteins and pathways. SU056 can enhance the cytotoxic effect

Condiciones de almacenamiento de almacenamiento

Store at -20°C

Enviado en

Ice chest + Ice pads

Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.

Pureza

≥98%

Nombres e identificadores

• Sonrisas canónicas: O=C1OCC2=C1C(C3=CC4=C(C=C3N2CCO)OCO4)C5=CC(F)=CC=C5
• Peso molecular: 369.34

Propiedades químicas y físicas

• Solubilidad: DMSO : 50 mg/mL (135.38 mM; Need ultrasonic)